Efficacy and safety of 4 doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: a phase II, 4-week, multicenter, randomized, double-blind, placebo-controlled trial. - Schnitzer,TJ.; Beier,J.; Geusens,P. (Arthritis Rheum, 2004)